Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hikma Pharmaceuticals ( (GB:HIK) ) has shared an announcement.
Hikma Pharmaceuticals has continued executing its $250 million share repurchase programme, buying back ordinary shares on the London Stock Exchange and Cboe Europe between 23 and 27 March 2026. Over this disclosure period it acquired several hundred thousand shares at prices around 1,223 to 1,269 pence and plans to cancel the repurchased stock, reducing the free float.
Since the buyback’s launch in late February, Hikma has purchased 3,761,014 shares for a total consideration of about £46.9 million, signalling ongoing capital return to shareholders. Following these transactions, the company now holds 12,833,233 shares in treasury and has 218,125,439 ordinary shares in issue, setting the current base for voting rights and potentially enhancing earnings per share over time.
The most recent analyst rating on (GB:HIK) stock is a Buy with a £1800.00 price target. To see the full list of analyst forecasts on Hikma Pharmaceuticals stock, see the GB:HIK Stock Forecast page.
Spark’s Take on HIK Stock
According to Spark, TipRanks’ AI Analyst, HIK is a Neutral.
The score is held back primarily by weakening cash generation and a notably bearish technical trend (oversold and trading below key moving averages). These are partially offset by attractive valuation (low P/E and strong dividend yield) and a constructive earnings-call outlook supported by guidance comfort and a GBP 250m buyback, despite near-term injectable headwinds.
To see Spark’s full report on HIK stock, click here.
More about Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational generic and specialty pharmaceutical company listed in London and on Nasdaq Dubai. The group focuses on supplying branded and non-branded generic medicines, injectables and specialty treatments to markets in the U.K., the U.S., MENA and other international regions, with a strategy centred on portfolio breadth and reliable supply.
Average Trading Volume: 1,312,917
Technical Sentiment Signal: Sell
Current Market Cap: £2.7B
For detailed information about HIK stock, go to TipRanks’ Stock Analysis page.